Elypta
Advancing cancer detection
Sweden
32 employees
Grant
Total: $107.83M
Biotechnology, Health Care
General Information
Get notified when Elypta moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
Sweden Market
Biotechnology
About Elypta
Taxonomy: Liquid Biopsy, Cancer Detection, Molecular Diagnostics, Glycosaminoglycans, Renal Cell Carcinoma, Clinical Development, Early Detection, Recurrence Surveillance, Treatment Response Monitoring, Medical Imaging, Metabolism-based Approach, Pan-cancer Potential, Mass-spectrometry, Research and Development
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 |
|
28 Mar 2023 |
| Series A | •••••• | 7 |
|
20 Jun 2022 |
| Seed Round | •••••• | 5 |
|
23 Jan 2020 |
| Grant | •••••• | 1 | •••• •••• | 01 Oct 2019 |
| Grant | •••••• | 1 | •••• •••• | 01 Jan 2019 |
Elypta Alternatives & Competitors
Easy, Accurate & Affordable Blood Based Screening for early detection of cancer and COVID-19 detecti...
LIQUID BIOPSY using disposable microfluidics to detect, take image, sort of Circulating Tumor Cells...
We are making early stage cancer easier to find.
FAQ About Elypta
Don't just browse. Track.
Signal Tracker monitors Elypta and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
